Deletion of the long arm of chromosome 5 (del(5q)) is a common finding in myelodysplastic syndrome (MDS) and in acute myeloid leukemia (AML 2 The WHO classification recognized that the 5q-syndrome is narrowly defined as de novo MDS with an isolated cytogenetic abnormality involving deletions between bands q21 and q32 of chromosome 5. The criteria for inclusion have evolved from the description by Van den Berghe et al.
1 to normal to increased megakaryocytes with hypolobated nuclei, o5% blasts, no Auer rods in bone marrow and normal or increased platelets and o5% blasts in blood. Furthermore, additional cytogenetic abnormalities or 5% or more blasts in the blood or marrow is exclusionary for the diagnosis.
2 Therefore, most of the patients (95%) with an isolated 5q deletion do not fit the WHO criteria to be included in this subset of MDS, which appears to be rare. 3, 4 For over 15 years, many studies have focused on defining the common deleted region of chromosome 5.
5 --10 Initially, the Knudson two-hit model was thought to occur in these large deletions. Now, the haploinsufficiency of one or more genes seems the model to explain 5q deletion consequences.
11
In this work, our objective was to characterize breakpoints of del(5q) among 70 MDS and 24 AML patients using fluorescence in situ hybridization (FISH). We identified not only the common deleted region but also the common retained regions in these 94 MDS/AML patients. We differentiated patients with isolated 5q deletion and those with additional chromosomal abnormalities.
Patients were distributed in two groups (Supplementary Table) . Group 1 consisted of patients with an apparently isolated del(5q) (46 patients: 42 MDS and 4 AML). In this group, we integrated five patients with MDS associated with isolated del(5q), according to the criteria of the revised WHO classification (bone marrow: normal to increased megakaryocytes with hypolobated nuclei, o5% blasts, no Auer rods; blood: platelets normal or increased, o5% blasts) (I25-I29). Group 2 included patients with del(5q) and additional cytogenetic abnormalities (48 patients: 28 MDS and 20
Accepted article preview online 17 January 2012; advance online publication, 31 January 2012 AML). Of these, 14/28 MDS patients and 19/20 AML patients had a complex karyotype (three or more chromosomal abnormalities).
A deletion of the long arm of chromosome 5 was detected by RHG (R-bands by heating using Giemsa) banding and confirmed by FISH techniques with LSI EGR1 5q31/D5S23,D5S721, LSI CSF1R 5q33/D5S23,D5S72 and 5p/5q subtelomeric probes (Abbott, Rungis, France). We excluded patients with complex 5q deletions (derivatives of chromosome 5 such as isochromosomes, derivatives resulting from a translocation with variable chromosomes, dicentrics and so on). An appropriate set of bacterial artificial chromosome clones distributed throughout chromosome 5 (referred on website http://genome.ucsc.edu) was used to determine both del(5q) proximal and distal breakpoints and the size of commonly deleted region (CDR) and commonly retained region (CRR) in each patient subpopulation (Figure 1) .
Location of the proximal and distal breakpoints was highly variable among patients in both groups (Figure 1) . No recurrent breakpoint was found. Deletions were large in all cases, the minimum size being 42 megabases (Mb) and 18 Mb in groups 1 and 2, respectively.
In group 1, FISH using a 5q subtelomeric probe showed that all the deletions were interstitial. The CDR encompassed 35 Mb (between bands q21.3 and q31.23) for MDS patients and 38 Mb (between bands q23.1 and q33.2) for AML patients. The shared CDR for MDS/AML patients encompassed 25 Mb (between bands q23.1 and q31.23). Proximal and distal CRRs were identified for MDS/AML patients, they covered pter to q14.1 bands and q35.1 to q35.3 bands, respectively ( Figure 1) .
In group 2, FISH using a 5q subtelomeric probe showed all the deletions to be interstitial, but for one MDS case (patient II22) in which the deletion was terminal. For this latter case, 24-color FISH using MetaSystems'24Xcyte probe kit (MetaSystems, Altlussheim, Germany) revealed no additional material from another chromosome. The CDR encompassed 5 Mb (from 5q31.1 to 5q31.3) and 8 Mb (from 5q32 to 5q33.2) in MDS and AML patients, respectively ( Figure 1) . A sole proximal CRR, including the whole short arm and bands 5q10 to 5q12.1, was observed in group 2. No distal CRR was observed for MDS patients. Patient II25 was particular. Indeed, FISH studies showed four clones with different deletions of chromosome 5 in each clone (Figure 1) .
In this study, we focused on 5q deletion confirmed by FISH techniques, excluding other chromosome 5 rearrangements. No array CGH was performed to identify possible cryptic chromosomal abnormalities. Although a wide distribution of breakpoints was observed in these 94 MDS/AML patients, the chromosomal segment in which the breakpoints occurred was different in group 1 and 2. Surprisingly, CDR was smaller in patients with del(5q) and additional abnormalities than in patients with isolated del(5q) (Figure 1) . In each group, CDR was larger and more distal in AML patients than in MDS patients. In group 2, no overlapping in the CDR segments was observed between MDS and AML patients. In our study, a complex karyotype was found in 50% and 95% of MDS and AML patients, respectively. The chromosomal instability related to other associated abnormalities could explain the greater variability of breakpoints.
In a review based on the studies that had defined the common deleted region of chromosome 5, 5 --10 Eisenmann et al. 12 reported two CDRs: CDR1 (from bands 5q32 to 5q33.1) in 5q-syndrome and CDR2 (from 5q31.1 to 5q31.2) in aggressive MDS and AML patients (Figure 2) . Comparison with the literature data is difficult because of differences in disease classification (5q-syndrome versus 5q deletion, aggressive disease and so on), lack of precision of the karyotypes, lack of verification by FISH or array CGH and so on, which could explain discrepancies between our results and those previously reported.
Combining groups 1 and 2, we described two different CDRs: MDS-CDR and AML-CDR. Our MDS-CDR (from bands 5q31.1 to 5q31.3) contains 42 genes expressed in bone marrow (http:// www.ncbi.nlm.nih.gov/projects/mapview/) and is more similar to the CDR2 described by Eisenmann et al.
12 This MDS-CDR affected patients with good or bad prognosis and is consistent with literature data. 12 Our AML-CDR (from 5q32 to 5q33.2) contains 101 genes expressed in bone marrow (http://www.ncbi.nlm.nih.gov/projects/ mapview/) and differs from CDR2 described by Eisenmann et al. 12 This commonly deleted segment is closer to the CDR1, present in 5q-syndrome patients (Figure 2 ). In contrast with previously published data, 4, 7, 12, 13 AML-CDR is distal to band 5q31. These observations highlight the heterogeneity of 5q deletions in myeloid neoplasms. Figure 1 . FISH results with LSI EGR1, LSI CSF1R, 5p and 5q subtelomeric probes and bacterial artificial chromosome clones located on the long arm of chromosome 5. Delineation of deleted (grey square) and retained (white square) regions for 46 patients in group 1 and 48 patients in group 2. In each group, we marked the boundary of CDR (dark-gray square) and CRR (dotted square).
We identified CRRs in groups 1 and 2 ( Figure 1) . Genes located on retained regions could also have a role in progression of myeloid disease. The distally retained region, only observed in group 1, contains 30 genes expressed in bone marrow (http:// www.ncbi.nlm.nih.gov/projects/mapview/). Combining groups 1 and 2, we described two proximal CRRs in MDS and AML patients (Figure 2 ). These CRRs contain more than 30 genes (http:// www.ncbi.nlm.nih.gov/projects/mapview/).
Patients with sole 5q deletions had large deletions and a large CDR with multiple genes contained in the deleted segment. In these cases, this chromosomal abnormality could be the initial event in MDS, inducing haploinsufficiency of several genes involved in proliferation and/or differentiation. Some cases of cryptic 5q deletions have been reported in the literature.
14 These cryptic 5q deletions are undoubtedly a rare event. 15 Up to date, many studies have focused on commonly deleted genes on 5q. Why are we only interested on genes located in CDRs? Understanding the interactions between deleted and retained genes could possibly help us to decipher the oncogenic mechanisms in myeloid hemopathies associated with 5q deletion. 
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